Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             280 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormal noradrenergic function in panic disorder and PTSD Charney, D.S.
1994
4 3 p. 257-258
2 p.
artikel
2 A comparison of moclobemide and sertraline in the treatment of depressive disorders Dönbak, S.
1994
4 3 p. 324-
1 p.
artikel
3 A comparison of the effects of sertraline and clomipramine on postural blood pressure changes and heart rate and blood pressure variability Coupland, N.J.
1994
4 3 p. 294-295
2 p.
artikel
4 ADH, aldosterone, angiotensin, renin, plasma-renin activity and cortisol in untreated schizophrinics with special relation to test therapy and treatment response Volz, H.-P.
1994
4 3 p. 373-374
2 p.
artikel
5 A double-blind comparison of sertraline and nortriptyline in the treatment of depressed geriatric outpatients Coffey, D.J.
1994
4 3 p. 333-334
2 p.
artikel
6 A double-blind, placebo-controlled comparison of fluvoxamine, with or without behaviour therapy, in panic disorder Simpson, R.J.
1994
4 3 p. 339-
1 p.
artikel
7 Alexithymia, cerebral lateralization and drug response in patients with panic disorder Kalinin, V.V.
1994
4 3 p. 336-
1 p.
artikel
8 A meta-analysis of the efficacy of selective serotonin reuptake inhibitors compared to tricyclic antidepressants in depression Anderson, I.
1994
4 3 p. 332-
1 p.
artikel
9 A multicentre, double-blind, controlled comparison of SeroquelTM and chlorpromazine in the treatment of hospitalised patients with acute exacerbation of subchronic and chronic schizophrenia Link, C.
1994
4 3 p. 385-
1 p.
artikel
10 A multicentre, double-blind, placebo-controlled comparison of low and high dosage regimens of SeroquelTM in the treatment of hospitalised patients with acute exacerbation of subchronic or chronic schizophrenia Hirsch, S.
1994
4 3 p. 384-385
2 p.
artikel
11 A multicentre, placebo-controlled, double-blind evaluation of SeroquelTM in hospitalised patients with acute exacerbation of chronic and subchronic schizophrenia Arvanitis, L.
1994
4 3 p. 385-
1 p.
artikel
12 β-Amyloidosis in the pathogenesis of Alzheimer's disease - possible molecular mechanisms Huber, G.
1994
4 3 p. 229-230
2 p.
artikel
13 Analysis of the effects of selegiline (L-deprenyl) on memory in Alzheimer's disease using Sternberg's paradigm Filip, V.
1994
4 3 p. 414-
1 p.
artikel
14 An evolution study of dementia of the Alzheimer type (DAT) in patients undergoing treatment with citicoline, calcium antagonist and piracetam during one year Loza, A.Soto
1994
4 3 p. 414-415
2 p.
artikel
15 A new drug with antiamnestic potential: EEG study Kaplan, A.Ya.
1994
4 3 p. 440-
1 p.
artikel
16 A new method to describe the impact of two antidepressant treatments in daily life Barge-Schaapveld, D.Q.C.M.
1994
4 3 p. 297-
1 p.
artikel
17 Animal models of memory impairment Costall, B.
1994
4 3 p. 182-184
3 p.
artikel
18 An investigation of effects of fluvoxamine and dothiepin on sleep and daytime sleepiness in normal volunteers Wilson, S.J.
1994
4 3 p. 313-
1 p.
artikel
19 An open trial with 7-methoxytacrine in tardive dyskinesia Maršálek, M.
1994
4 3 p. 369-
1 p.
artikel
20 An overlap between schizophrenia and affective disorders: preliminary results of a family study Knobler, H.Y.
1994
4 3 p. 374-
1 p.
artikel
21 Anti-cardiolipin AB in multicase families with schzophrenia Sirota, P.
1994
4 3 p. 381-
1 p.
artikel
22 Anticonvulsive effect of some psychotropic drugs and benzamine derivatives with regard to antimonoamine oxidase activity Goldina, O.A.
1994
4 3 p. 445-446
2 p.
artikel
23 Anxiety and aggression as pacemakers of serotonin-related depression van Praag, H.M.
1994
4 3 p. 196-197
2 p.
artikel
24 Anxiolytic activity of single doses of the 5-HT3 antagonist zacopride Ansseau, M.
1994
4 3 p. 355-
1 p.
artikel
25 A randomised dosage increase in patients not responding to paroxetine and maprotiline Angersbach, D.H.
1994
4 3 p. 288-289
2 p.
artikel
26 Are higher doses more effective in OCD? Fineberg, N.A.
1994
4 3 p. 264-265
2 p.
artikel
27 Are SSRIs useful in obsessive-compulsive personality disorder? Ansseau, M.
1994
4 3 p. 266-267
2 p.
artikel
28 A review of methodological approaches for analysing clinical trials on depressed patients: intention to treat and on treatment principles Lehert, Ph.
1994
4 3 p. 325-326
2 p.
artikel
29 Association between schizophrenia and the dopamine receptor DRD4 Macciardi, F.
1994
4 3 p. 375-376
2 p.
artikel
30 Author index to this issue 1994
4 3 p. 449-450
2 p.
artikel
31 Autism and the pro-opiomelanocortin system Buitelaar, J.K.
1994
4 3 p. 244-245
2 p.
artikel
32 Behavioral and neuroimmune effects of anapsos in cognitively impaired rats Alvarez, X.A.
1994
4 3 p. 397-398
2 p.
artikel
33 Behavioral effects of non-benzodiazepine anxiolytic drugs - tolerance and memory Nowakowska, E.
1994
4 3 p. 346-347
2 p.
artikel
34 Behavioral reactions, memory, neurophysiological and neurochemical changes in brain after application of analgesics Zlenko, H.
1994
4 3 p. 443-444
2 p.
artikel
35 Behavioral sensitization to drugs of abuse Nencini, Paolo
1994
4 3 p. 207-208
2 p.
artikel
36 Bipolar affective disorder is not linked to norepinephrine transporter protein or serotonin transporter protein genes Gelernter, J.
1994
4 3 p. 316-
1 p.
artikel
37 Brain cholecystokinin levels and receptor binding in anxiety states Harro, J.
1994
4 3 p. 352-
1 p.
artikel
38 Brofaromine versus fluvoxamine in panic disorder van Vliet, I.M.
1994
4 3 p. 356-357
2 p.
artikel
39 Bromocriptine — further behavioural and biochemical studies Jackson, D.M.
1994
4 3 p. 422-
1 p.
artikel
40 Candidate gene study of the catecholamine system in schizophrenia Crowe, R.R.
1994
4 3 p. 373-
1 p.
artikel
41 Cerebral asymmetry in emotional control, mechanisms of mood disorders and therapy Deglin, V.L.
1994
4 3 p. 415-
1 p.
artikel
42 Cerebral blood flow in symptomatic closed cranial injury patients Bonne, O.B.
1994
4 3 p. 442-
1 p.
artikel
43 Cerebral glucose metabolic changes after stereotactic leukotomy for refractory obsessive-compulsive disorder: a case report François, A.
1994
4 3 p. 361-
1 p.
artikel
44 Characterological basis of mixed anxiety and depression Hirschfeld, Robert M.A.
1994
4 3 p. 167-168
2 p.
artikel
45 Clinical diagnosis of Alzheimer's disease (AD) Korczyn, Amos D.
1994
4 3 p. 241-
1 p.
artikel
46 Clinically relevant effect sizes in depression Montgomery, Stuart A.
1994
4 3 p. 283-284
2 p.
artikel
47 Clinically relevant measures of change in Alzheimer's patients Schwartz, Gerri E.
1994
4 3 p. 240-241
2 p.
artikel
48 Clomipramine challenge test in obsessive-compulsive disorder: an indicator for altered serotonergic activity/neuroendocrine responsivity? Martinez, B.
1994
4 3 p. 341-
1 p.
artikel
49 35% CO2 model in panic disorder: a genetic perspective Perna, G.
1994
4 3 p. 343-
1 p.
artikel
50 Comparative study of [3H]serotonin uptake, [3H]imipramine and [3H]paroxetine binding on platelets from drug-free panic disorder patients Magyar, I.
1994
4 3 p. 342-
1 p.
artikel
51 Contingent negative variation (CNV) in mood disorders Papart, P.
1994
4 3 p. 323-
1 p.
artikel
52 Cortisol and prolactin response to fenfluramine in suicidal patients Sirota, P.
1994
4 3 p. 432-
1 p.
artikel
53 D2 and 5-HT2 receptor occupancy in antipsychotic drug treated patients Farde, L.
1994
4 3 p. 221-223
3 p.
artikel
54 (−)Deprenyl fails to potentiate phenyl-ethyl-amine-induced place preference conditioning Timár, J.
1994
4 3 p. 404-
1 p.
artikel
55 Description and risk factors of the serotonin syndrome in depressed patients treated with tricyclic antidepressants Lejoyeux, M.
1994
4 3 p. 294-
1 p.
artikel
56 Differences between panic disorder and generalized anxiety disorder patients in response to alprazolam treatment and withdrawal Klein, E.
1994
4 3 p. 275-277
3 p.
artikel
57 Differences in regional cerebral blood flow/SPECT scan between major depression and chronic fatigue syndrome Fischler, B.
1994
4 3 p. 312-
1 p.
artikel
58 Differential diagnosis and possible pathogenetic mechanisms of obsessive-compulsive syndromes Müller, N.
1994
4 3 p. 360-361
2 p.
artikel
59 Differential induction of early gene expression in the CNS by antipsychotics Rogue, P.
1994
4 3 p. 390-
1 p.
artikel
60 Disturbance of serotonergic or glutamatergic neurotransmission results in hyperfrontality as measured by PET and FDG in acute human model psychoses Vollenweider, F.X.
1994
4 3 p. 367-
1 p.
artikel
61 Does concurrent lithium administration potentiate the antidepressant effect of desipramine? Bloch, M.
1994
4 3 p. 299-300
2 p.
artikel
62 Dopamine D1 and D5 receptors: molecular cloning and pharmacological characteristics Monsma Jr., F.J.
1994
4 3 p. 194-195
2 p.
artikel
63 Dopamine neurotoxic effects on mitochondrial respiration Ben-Shachar, D.
1994
4 3 p. 259-260
2 p.
artikel
64 Dopaminergic and serotonergic mechanism in ECS Vetulani, J.
1994
4 3 p. 214-215
2 p.
artikel
65 Dotarizine prevent electroconvulsive shock- and pentylenetetrazol-induced amnesia in rats Lazarova-Bakarova, M.B.
1994
4 3 p. 404-405
2 p.
artikel
66 Dothiepin tolerability in general practice through two assessment scales of somatization Schmitt, L.
1994
4 3 p. 298-
1 p.
artikel
67 Drugs as tools for investigating memory Danion, J.M.
1994
4 3 p. 179-180
2 p.
artikel
68 Duration of untreated psychosis during first year of illness as a predictor of prognosis in schizophrenia Rzewuska, M.
1994
4 3 p. 392-
1 p.
artikel
69 Earlier onset of psychostimulant use and the D2 dopamine receptor gene TaqI A1 RFLP predict preferential psychostimulant use in polysubstance abusers Persico, A.M.
1994
4 3 p. 409-410
2 p.
artikel
70 ECT and cognitive function of psychotic patients Mahnik, M.
1994
4 3 p. 447-
1 p.
artikel
71 EEG abnormalities in clozapine-treated schizophrenic patients Treves, I.A.
1994
4 3 p. 393-395
3 p.
artikel
72 EEG coherence and psychological estimation of the effects of amiridin and izotiorbamin in patients with craniocerebral trauma Zhavoronkova, L.
1994
4 3 p. 433-434
2 p.
artikel
73 Effect of antiparkinson drugs on memory in medicated chronic schizophrenics Silver, H.
1994
4 3 p. 391-
1 p.
artikel
74 Effect of diazepam on punished drinking and on plasma corticosterone levels in male and female rats Peričić, D.
1994
4 3 p. 345-346
2 p.
artikel
75 Effect of normal aging on 5-HT1A receptor mediated temperature and hormone responses Gelfin, G.
1994
4 3 p. 406-407
2 p.
artikel
76 Effect of the cholecystokinin B receptor antagonist L-365-260 on lactate induced panic attacks van Megen, H.J.G.M.
1994
4 3 p. 354-355
2 p.
artikel
77 Effects of antidepressants on cyclic AMP responses in the living rat Gur, E.
1994
4 3 p. 317-318
2 p.
artikel
78 Effects of electroconvulsive treatment on lymphocytes of depressed patients Marazziti, D.
1994
4 3 p. 290-
1 p.
artikel
79 Effects of 5-HT1A receptor antagonists after acute and chronic citalopram treatment on the activity of 5-HT cells in the dorsal raphe nucleus Svensson, T.H.
1994
4 3 p. 320-
1 p.
artikel
80 Effects of inositol on lithium-induced EEG abnormalities Barak, Y.
1994
4 3 p. 419-
1 p.
artikel
81 Effects of Polypodium leucotomos (difur) on behavioral parameters and brain neuroimmune factors in nbM-lesioned rats Alvarez, X.A.
1994
4 3 p. 399-
1 p.
artikel
82 Effects of several psychotropic drugs on long-lasting rhythmic and emotional effects induced by early atypical Zeitgeber. A possible simulation of depression? Schelstraete, I.
1994
4 3 p. 326-
1 p.
artikel
83 Effects of S-12024 on brain electrical activity in patients with Alzheimer's disease Franco-Maside, A.
1994
4 3 p. 410-411
2 p.
artikel
84 Effects of S-12024 on middle cerebral artery blood flow velocities in Alzheimer's disease: a transcranial doppler study Caamaño, J.
1994
4 3 p. 397-
1 p.
artikel
85 Effects of the AT1 and AT2 nonpeptide receptor antagonists DuP753 (Losartan) and PD 123 319 on seizure susceptibility Georgiev, V.P.
1994
4 3 p. 427-428
2 p.
artikel
86 Efficacy of olanzapine in the positive and negative symptoms of schizophrenia Wood, A.J.
1994
4 3 p. 224-225
2 p.
artikel
87 Electroconvulsive therapy affects platelet peripheral-type benzodiazepine receptors Weizman, R.
1994
4 3 p. 325-
1 p.
artikel
88 Electrophysiological evidence that desmethylsertraline is inactive at blocking central 5-HT uptake in vivo Sprouse, J.
1994
4 3 p. 327-
1 p.
artikel
89 Elevated plus maze activity and serotonergic neurotransmission in Fawn-Hooded rats Briley, M.
1994
4 3 p. 337-338
2 p.
artikel
90 Endorphins, emotional stress and experimental cocaine addiction van Ree, Jan M.
1994
4 3 p. 208-210
3 p.
artikel
91 Epidemiology and psychiatric background variables of parasuicidal behavior; results of the WHO/EURO multicenter prediction study Hawellek, B.
1994
4 3 p. 368-
1 p.
artikel
92 Evaluation of lithium treatment in alcoholism: a review Lejoyeux, M.
1994
4 3 p. 402-
1 p.
artikel
93 Experimental models of human anxiety — efficacy of antipanic agents Olivier, B.
1994
4 3 p. 268-270
3 p.
artikel
94 Expressed emotion (EE) of families of psychotic inpatients: its effect on outcome and on neuroleptic efficacy Marom, S.
1994
4 3 p. 390-391
2 p.
artikel
95 Ex vivo monitoring of serotonin transport and serotonin level in rat platelets in the course of treatment with antidepressant drugs Jernej, B.
1994
4 3 p. 306-307
2 p.
artikel
96 Fear conditioning and extinction: Basic neuronal mechanisms related to PTSD Davis, Michael
1994
4 3 p. 252-254
3 p.
artikel
97 Fluoxetine challenge test and personality dimesions in normal volunteers Cabranes, J.A.
1994
4 3 p. 319-
1 p.
artikel
98 Fluoxetine in the treatment of poststroke depression: a pilot study Stamenkovic, M.
1994
4 3 p. 306-
1 p.
artikel
99 Fluphenazine and clozapine in chronic psychotic patients: a pilot study Kores, B.P.
1994
4 3 p. 383-384
2 p.
artikel
100 Fluvoxamine-induced delayed sleep phase syndrome in ten patients with obsessive-compulsive disorder Hermesh, H.
1994
4 3 p. 358-
1 p.
artikel
101 From ‘real’ pharmacotherapeutic problems in schizophrenia to an ‘ideal’ pharmacodynamic profile for neuroleptics Altamura, A.C.
1994
4 3 p. 219-220
2 p.
artikel
102 Functional expression and properties of NMDA receptor subtypes Avenet, P.
1994
4 3 p. 260-261
2 p.
artikel
103 GABA and flunitrazepam binding inhibitor levels in native plasma of healthy women, healthy men and male schizophrenic patients Tvrdeić, A.
1994
4 3 p. 378-
1 p.
artikel
104 Genetic control of the metabolism of neuroleptics: implications for the management of therapeutic dosages and side effects Marino, C.
1994
4 3 p. 376-377
2 p.
artikel
105 Genetic linkage and association studies of schizophrenia and related disorders using dopamine transporter gene markers Persico, A.M.
1994
4 3 p. 379-
1 p.
artikel
106 Globus pallidus and reward Spyraki, C.
1994
4 3 p. 206-
1 p.
artikel
107 Glutamatergic modulation of dopamine functions Ögren, S.O.
1994
4 3 p. 172-173
2 p.
artikel
108 Haptoglobin levels in a chronic mild stress model of depression in rats before and after treatment Sluzewska, A.
1994
4 3 p. 302-
1 p.
artikel
109 [3H]Imipramine in posttraumatic patients Weizman, R.
1994
4 3 p. 362-
1 p.
artikel
110 How resistant is resistant depression? Focus on electroconvulsive therapy Lerer, B.
1994
4 3 p. 211-212
2 p.
artikel
111 5-HT3 receptor antagonists, cognition and schizophrenia Costall, B.
1994
4 3 p. 181-182
2 p.
artikel
112 Human platelets respond to nerve growth factor Prokudin, V.Yu.
1994
4 3 p. 446-447
2 p.
artikel
113 I.c.v. inositol does not reverse seizures elicited by the inositol monophosphatase inhibitor R-76COONa and pilocarpine Agam, G.
1994
4 3 p. 423-424
2 p.
artikel
114 Impact of the competitive and the noncompetitive antagonists CGP 40 116 and MK-801 respectively, on the dopamine turnover in the ventral tegmental area of rats Wȩdzony, K.
1994
4 3 p. 444-445
2 p.
artikel
115 Impairment of cognitive function in X-linked adrenoleukodystrophy Maurer, I.
1994
4 3 p. 409-
1 p.
artikel
116 Impairment of strategies underlying verbal fluency performance in schizophrenia; relationships with prefrontal cortex dysfunction Robert, Ph.
1994
4 3 p. 380-
1 p.
artikel
117 Implications of sensitization and kindling models for the evolution and treatment of post-traumatic stress disorder (PTSD) Post, R.M.
1994
4 3 p. 254-255
2 p.
artikel
118 Influence of nifedipine on the clinical picture of endogenous affective disorders Panteleyeva, G.P.
1994
4 3 p. 289-
1 p.
artikel
119 Initial antidepressant drug treatment effect as a predictor for outcome after 8 weeks Volz, H.-P.
1994
4 3 p. 296-
1 p.
artikel
120 Inositol Belmaker, R.H.
1994
4 3 p. 165-166
2 p.
artikel
121 Inositol trisphosphate and cytosolic calcium level in activated platelets of schizophrenics Řípová, D.
1994
4 3 p. 371-
1 p.
artikel
122 Inpatient opiate detoxification with levomethadone and comedication Krappel, C.
1994
4 3 p. 408-
1 p.
artikel
123 Interactions between γ-type endorphins and brain dopamine systems Wolterink, G.
1994
4 3 p. 176-177
2 p.
artikel
124 Internal consistency of a new scale for the evaluation of benzodiazepine withdrawal syndrome Cesana, B.M.
1994
4 3 p. 411-
1 p.
artikel
125 Involvement of cholinergic activity of the caudate-putamen in memory consolidation: a mapping study Quirarte, G.
1994
4 3 p. 422-423
2 p.
artikel
126 Involvement of 5-hydroxytryptamine-1C (5-HT1C) receptors in m-chlorophenylpiperazine-induced antinociception Chojnacka-Wójcik, E.
1994
4 3 p. 436-
1 p.
artikel
127 Involvement of L-type voltage-dependent calcium channel in apomorphine motility but not stereotypy Muchaluk, J.
1994
4 3 p. 430-431
2 p.
artikel
128 Is social phobia a relevant illness? Bakish, D.
1994
4 3 p. 185-186
2 p.
artikel
129 Levomepromazine — a substrate of cytochrome CYP2D6? Höflich, G.
1994
4 3 p. 370-
1 p.
artikel
130 Lithium and treatment of aggressive behaviour Tyrer, S.P.
1994
4 3 p. 234-236
3 p.
artikel
131 Lithium effects on DNA damage and repair of actively transcribed genes Sirota, P.
1994
4 3 p. 433-
1 p.
artikel
132 Lithium interferes with coupling of serotonin receptors to their G proteins Wang, H.-Y.
1994
4 3 p. 317-
1 p.
artikel
133 Lithium monitoring systems Kehoe, R.F.
1994
4 3 p. 448-
1 p.
artikel
134 Lithium potentiation and treatment of refractory depression Dinan, T.G.
1994
4 3 p. 216-
1 p.
artikel
135 Long-term effects of SSRIs and TCAs on sleep Wilson, S.J.
1994
4 3 p. 314-
1 p.
artikel
136 Long-term fluvoxamine treatment and platelet-rich plasma serotonin level in symptom-free panic disorder patients Faludi, G.
1994
4 3 p. 336-337
2 p.
artikel
137 Long-term treatment of depression Keller, Martin B.
1994
4 3 p. 205-
1 p.
artikel
138 Major depression and SPECT brain imaging with HMPAO-99mTc: pre and during treatment assessements Thomas, P.
1994
4 3 p. 309-
1 p.
artikel
139 Mechanisms of stress analgesia opioid and adrenergic types of behaviour Cristea, A.N.
1994
4 3 p. 427-
1 p.
artikel
140 Memory effects of the natural product Mumyo on the water maze in rats Spassov, V.
1994
4 3 p. 396-
1 p.
artikel
141 Memory systems: current perspectives from psychopharmacology Valerie Curran, H.
1994
4 3 p. 178-179
2 p.
artikel
142 Metabotropic glutamate receptors and neuronal apoptosis in culture Nicoletti, F.
1994
4 3 p. 278-279
2 p.
artikel
143 Methods of estimating onset of improvement Stassen, H.H.
1994
4 3 p. 284-285
2 p.
artikel
144 Mixed anxiety-depression: prevalence recognition and disability in the WHO-PPGHC study Lecrubier, Yves
1994
4 3 p. 169-170
2 p.
artikel
145 Moclebemide in treating patients with post-traumatic stress disorder Folnegović-Šmalc, V.
1994
4 3 p. 344-345
2 p.
artikel
146 Moclobemide and clomipramine in resistant depressions. Six months of combined use Soria, C.A.
1994
4 3 p. 307-308
2 p.
artikel
147 Mode of action of neuroleptic drugs: role of 5-HT2 receptor antagonism Svensson, Torgny H.
1994
4 3 p. 173-
1 p.
artikel
148 Modifications of platelet markers during treatment with fluvoxamine of patients with obsessive-compulsive disorder Marazziti, D.
1994
4 3 p. 338-
1 p.
artikel
149 Modulation of glutamate uptake by oxygen free radicals and changes in the expression of NMDA receptor subunits: relevance to neurotoxicity Racagni, G.
1994
4 3 p. 261-262
2 p.
artikel
150 Molecular modeling and function of neuronal transporters Edvardsen, Ø.
1994
4 3 p. 250-251
2 p.
artikel
151 Movement disorders in schizophrenia and implications for dosage of old and new antipsychotics Barnes, Thomas R.E.
1994
4 3 p. 223-224
2 p.
artikel
152 Muscarinic M1 and M2 receptor mechanisms in the regulation of in vivo acetylcholine release in the rat striatum Ögren, S.O.
1994
4 3 p. 426-
1 p.
artikel
153 Musical hallucinations as a form of obsession Hermesh, H.
1994
4 3 p. 359-
1 p.
artikel
154 Nerve growth factor receptor on human platelets: identification and mechanism of platelet activation Brusov, O.S.
1994
4 3 p. 424-425
2 p.
artikel
155 Neurobiology and drug treatment of Tourette's syndrome and other tic disorders Rothenberger, A.
1994
4 3 p. 245-247
3 p.
artikel
156 Neurochemical and behavioral evidence for a central indirect dopaminergic agonist activity of the antidepressant medifoxamine in mice Vaugeois, J.-M.
1994
4 3 p. 323-324
2 p.
artikel
157 Neuroendocrine responses to pharmacological challenge in aggression Coccaro, E.F.
1994
4 3 p. 237-238
2 p.
artikel
158 Neuropsychological performances in hyponoradrenergic and hyposerotonergic syndrome in depression: search for predictive profile Paunović, V.R.
1994
4 3 p. 327-328
2 p.
artikel
159 New approaches to panic disorder Bourin, Michel
1994
4 3 p. 270-273
4 p.
artikel
160 New approach to treatment of social phobia Buller, R.
1994
4 3 p. 187-188
2 p.
artikel
161 New biochemical and genetic findings related to aggression: a review Ackenheil, M.
1994
4 3 p. 236-237
2 p.
artikel
162 Nimodipine in the treatment of primary degenerative dementia Cutler, N.R.
1994
4 3 p. 243-
1 p.
artikel
163 Norharman and platelet serotonin in panic disorder patients compared with healthy controls Timmerman, L.
1994
4 3 p. 353-354
2 p.
artikel
164 Normalization of the diminished prolactin response to buspirone in major depression during imipramine treatment Landowski, J.
1994
4 3 p. 321-
1 p.
artikel
165 Normal tau protein and hyperphosphorylated tau protein in cerebrospinal fluid: a biochemical marker for Alzheimer's disease? Blennow, K.
1994
4 3 p. 401-402
2 p.
artikel
166 OCD and Gilles de la Tourette syndrome — therapeutic issues and implications for mechanism Ratzoni, Gidi
1994
4 3 p. 265-266
2 p.
artikel
167 Outcome of anxiety and depression in general health care: a three-wave 3.5-year study of psychopathology, disability and life stress Ormel, J.
1994
4 3 p. 168-169
2 p.
artikel
168 Oxidant stress effects on nigral cell death: Prospects for neuroprotection Youdim, Moussa B.H.
1994
4 3 p. 226-228
3 p.
artikel
169 Participation of excitatory amino acids transmitter mechanisms in the anticonvulsive activity of barbiturate derivatives Guetova-Spassova, D.P.
1994
4 3 p. 420-421
2 p.
artikel
170 Patient cognitions as a useful diagnostic indicator in the differentiation of non-ischemic from ischemic chest pain Fraenkel, Yehudah M.
1994
4 3 p. 362-363
2 p.
artikel
171 Patients prefer drug therapy in panic disorder Bandelow, B.
1994
4 3 p. 348-349
2 p.
artikel
172 Peripheral-type benzodiazepine receptors in posttraumatic patients following the Gulf war Weizman, R.
1994
4 3 p. 357-
1 p.
artikel
173 PET studies of 5-HT metabolism in depression Ågren, H.
1994
4 3 p. 198-199
2 p.
artikel
174 Pharmacokinetics of fluvoxamine after intravenous and oral administration van Harten, J.
1994
4 3 p. 331-
1 p.
artikel
175 Pharmacological control by piracetam and aniracetam of cognitive deficits in rats with fetal alcohol syndrome Vaglenova, J.V.
1994
4 3 p. 403-
1 p.
artikel
176 Pharmacological effects of rimcazole and 1,3-di-o-tolylguanidine, sigma receptor ligands, as potential antipsychotic agents Maj, J.
1994
4 3 p. 386-387
2 p.
artikel
177 Pharmacological treatment of mixed anxiety and depression Kasper, S.
1994
4 3 p. 170-171
2 p.
artikel
178 Pharmacology and therapeutic actions of drugs which inhibit neuronal transporters Langer, S.Z.
1994
4 3 p. 249-250
2 p.
artikel
179 Pharmacotherapy for ‘pure’ dysthymia: setraline vs. imipramine and placebo Kocsis, J.H.
1994
4 3 p. 204-
1 p.
artikel
180 Phenytoin normalizes ERPs among impulsive aggressive inmates Barratt, E.S.
1994
4 3 p. 431-
1 p.
artikel
181 Phosphoinositide signalling system in resting platelets of schizophrenics Řípová, D.
1994
4 3 p. 372-
1 p.
artikel
182 Piracetam and fipexide abolish the amnesia provoked by PTZ kindling in rats Genkova-Papazova, M.
1994
4 3 p. 405-406
2 p.
artikel
183 Placebo-controlled study of clomipramine in panic patients taking benzodiazepines Ansseau, M.
1994
4 3 p. 356-
1 p.
artikel
184 Plasma β-endorphin in depressed patients Escapat, P.
1994
4 3 p. 315-
1 p.
artikel
185 Plasma levels of the enantiomers of mianserin in CYP2D6-genotyped patients Eap, C.B.
1994
4 3 p. 304-
1 p.
artikel
186 Platelet serotonergic markers related to impulsiveness and borderline personality traits in recurrent suicidal behaviour Verkes, R.J.
1994
4 3 p. 439-440
2 p.
artikel
187 Possible neurobiological basis for drug resistance in major depression de Montigny, C.
1994
4 3 p. 217-218
2 p.
artikel
188 Postnatal depression and peripartum progesterone levels: lack of a direct association Harris, B.
1994
4 3 p. 330-331
2 p.
artikel
189 Provocation of aggressive and autoaggressive behavior by psychoactive drugs Möller, H.-J.
1994
4 3 p. 232-234
3 p.
artikel
190 Psychological and neurochemical aspects in usual and successful cerebral aging Marchesi, G.F.
1994
4 3 p. 407-
1 p.
artikel
191 Psychopharmacological effects of low doses of fluoxetine in healthy volunteers: a comparative amphetamine controlled study Warot, D.
1994
4 3 p. 292-
1 p.
artikel
192 Psychopharmacology of suicide Träskman-Bendz, L.
1994
4 3 p. 231-232
2 p.
artikel
193 Psychophysiological patterns in panic patients before and after amitriptyline treatment Vein, A.M.
1994
4 3 p. 351-
1 p.
artikel
194 Psychotropic drugs and cerebral asymmetry in psychosis Egorov, A.Y.
1994
4 3 p. 364-
1 p.
artikel
195 Psychotropic medication and the suicidal patient: is there a different drug treatment in depressed patients with or without suicidal tendency? Laux, G.
1994
4 3 p. 310-
1 p.
artikel
196 Purification and characterization of the serotonin transporter from human brain Rotondo, A.
1994
4 3 p. 290-291
2 p.
artikel
197 Recent progress in dopamine transporter research Kuhar, M.J.
1994
4 3 p. 248-249
2 p.
artikel
198 Regional cerebral blood flow and antidepressant treatment response. Preliminary results D'haenen, H.
1994
4 3 p. 311-312
2 p.
artikel
199 Regional cerebral blood flow before and after low doses of amisulpride in negative schizophrenia Vaiva, G.
1994
4 3 p. 381-
1 p.
artikel
200 Regulation of the forskolin-stimulated cyclic AMP accumulation by corticosterone Czyrak, A.
1994
4 3 p. 444-
1 p.
artikel
201 Regulatory measures of clinically relevant response van Zwieten-Boot, B.J.
1994
4 3 p. 285-286
2 p.
artikel
202 Response to lithium therapy and the TH gene Cauli, G.
1994
4 3 p. 301-
1 p.
artikel
203 Results of a drug monitoring study on moclobemide in general practice Laux, G.
1994
4 3 p. 309-310
2 p.
artikel
204 Results of 8-year experience in treating female patients with affective disorder Hotujac, Lj.
1994
4 3 p. 448-
1 p.
artikel
205 Reversal of shuttle-box deficit by 1-phenyl-2-propylaminopentane (PPAP) Gyarmati, S.
1994
4 3 p. 298-299
2 p.
artikel
206 Risperidone in the treatment of therapy-resistant schizophrenia: four case histories Petersson, E.
1994
4 3 p. 387-388
2 p.
artikel
207 Seizure threshold and the treatment of major depression by electroconvulsive therapy Shapira, B.
1994
4 3 p. 300-301
2 p.
artikel
208 Selective actions of the novel atypical antipsychotic drug amperozide in the limbic forebrain Nomikos, G.G.
1994
4 3 p. 388-389
2 p.
artikel
209 Sensation seeking attitudes and risk-taking behaviors López-Ibor Jr., J.J.
1994
4 3 p. 199-200
2 p.
artikel
210 Serotonergic augmentation of typical and atypical antipsychotics in treatment-resistant chronic schizophrenia Silver, H.
1994
4 3 p. 392-
1 p.
artikel
211 Serotonin mechanisms in schizophrenia Meltzer, H.Y.
1994
4 3 p. 197-
1 p.
artikel
212 Serotonin stimulation of GTP binding in rat hippocampal membranes and the action of antidepressant drugs Segman, R.
1994
4 3 p. 318-
1 p.
artikel
213 Serum cholesterol concentration in suicide attempters: a case-control study Abbar, M.
1994
4 3 p. 429-430
2 p.
artikel
214 Serum levels of fluphenazine in schizophrenic outpatients maintained on two reduced doses of fluphenazine decanoate Heresco-Levy, U.
1994
4 3 p. 385-386
2 p.
artikel
215 Shortened REM latency in severe depression. A correlate of outcome Grunhaus, L.
1994
4 3 p. 213-214
2 p.
artikel
216 Significance of CCK-B receptors in the neurobiology of panic disorder Den Boer, J.A.
1994
4 3 p. 273-275
3 p.
artikel
217 Similar effects of non-competitive and competitive NMDA antagonists in conditioned place preference in rats Papp, M.
1994
4 3 p. 412-413
2 p.
artikel
218 Simulation of panic anxiety in animals with aversive intracerebral stimulation: elements of face and predictive validity Jenck, F.
1994
4 3 p. 349-
1 p.
artikel
219 Single-photon emission computed tomography and obsessive-compulsive disorder Martinez, B.
1994
4 3 p. 340-
1 p.
artikel
220 S 9977-2 normalizes behavior and brain interleukin-1β levels in rats with lesions in the nucleus basalis of Meynert Alvarez, X.A.
1994
4 3 p. 398-
1 p.
artikel
221 Social phobia in general health care Weiller, E.
1994
4 3 p. 186-
1 p.
artikel
222 Sources of differentiation of cocaine withdrawal symptomatology Mannelli, P.
1994
4 3 p. 400-
1 p.
artikel
223 Species differences in susceptibility to Li-pilocarpine seizures Bersudsky, Y.
1994
4 3 p. 428-429
2 p.
artikel
224 Spectral analysis of fluctuations in heart rate and blood pressure before and after treatment with imipramine or mirtazapine (ORG.3770) in major depressive disorder Tulen, J.H.M.
1994
4 3 p. 328-329
2 p.
artikel
225 SSRIs in depressed elderly; a double-blind comparison of sertraline and fluoxetine in depressed geriatric outpatients Newhouse, P.A.
1994
4 3 p. 332-333
2 p.
artikel
226 Stress systems in the brain: molecules, nuclei and circuits Watson, S.J.
1994
4 3 p. 252-
1 p.
artikel
227 Structure/function relationship of the dopamine D2 receptors Borelli, E.
1994
4 3 p. 192-193
2 p.
artikel
228 Tardive dyskinesia in a Scottish psychiatric hospital population Livingston, M.G.
1994
4 3 p. 387-
1 p.
artikel
229 The basic cellular changes in degenerative dementia — neuronal atrophy and loss of synapses Brun, A.
1994
4 3 p. 411-412
2 p.
artikel
230 The biphasic effects of ethanol on sleep latency Roth, T.
1994
4 3 p. 437-
1 p.
artikel
231 The brain kynurenine pathway: relevance in neurological disease Schwarcz, R.
1994
4 3 p. 228-
1 p.
artikel
232 The cognitive and psychomotor effects of acute of fluvoxamine and dothiepin in healthy volunteer subjects Sherwood, N.
1994
4 3 p. 303-
1 p.
artikel
233 The 4-dedimethylamino derivative of tetracycline loses both ability to block cyclic AMP accumulation and ability to inhibit rat motor activity Kofman, O.
1994
4 3 p. 419-420
2 p.
artikel
234 The difference among effects of haloperidol, (−)-sulpiride and SCH23390 on the expression of c-fos and c-jun mRNA inductions Ozaki, T.
1994
4 3 p. 365-
1 p.
artikel
235 The dopamine D3 receptor in nucleus accumbens: selective cellular localisation, function and regulation Schwartz, J.-C.
1994
4 3 p. 190-191
2 p.
artikel
236 The effect of antidepressant drugs and electroconvulsive shock on the rat hippocampal corticosteroid receptors Przegaliński, E.
1994
4 3 p. 308-309
2 p.
artikel
237 The effect of chronic lithium treatment on the caliber of the sural nerve in rats Licht, R.W.
1994
4 3 p. 310-311
2 p.
artikel
238 The effect of chronic peripheral inositol administration on Li-pilocarpine seizures and rat brain inositol levels Agam, G.
1994
4 3 p. 416-
1 p.
artikel
239 The effect of inositol on cognitive processes and mood states in normal volunteers Levine, J.
1994
4 3 p. 417-
1 p.
artikel
240 The effect of long-term morphine treatment on corticosteroid receptors in the rat hippocampus Budziszewska, B.
1994
4 3 p. 435-
1 p.
artikel
241 The effect of transcranial magnetic stimulation compared with electroconvulsive shock on rat apomorphine-induced stereotypy Fleischmann, A.
1994
4 3 p. 449-
1 p.
artikel
242 The effects of drugs acting at the GABA-benzodiazepine-barbiturate receptor complex on the behavior of sleep deprived mice Pokk, P.
1994
4 3 p. 344-
1 p.
artikel
243 The effects of hydergine on the MAO activity of the aged and adult rat brain Hariri, N.I.
1994
4 3 p. 399-400
2 p.
artikel
244 The effects of repeated morphine on the level of thyrotropin-releasing hormone and its receptors in the brain of the rat Jaworska-Feil, L.
1994
4 3 p. 434-
1 p.
artikel
245 The enigma of sigma receptors Leonard, B.E.
1994
4 3 p. 174-175
2 p.
artikel
246 The epidemiology of dysthymia Angst, Jules
1994
4 3 p. 203-
1 p.
artikel
247 The flesinoxan/5-HT1A receptor challenge and suicidal behavior Ansseau, M.
1994
4 3 p. 322-323
2 p.
artikel
248 The flesinoxan/5-HT1A receptor challenge in major depression Ansseau, M.
1994
4 3 p. 321-322
2 p.
artikel
249 The 5-HT1A receptor subtype in various regions of the human brain Palego, L.
1994
4 3 p. 425-
1 p.
artikel
250 The involvement of voltage-dependent calcium channel in the mechanism of ECS action Antkiewicz-Michaluk, L.
1994
4 3 p. 418-419
2 p.
artikel
251 The limbic location of some central effects of competitive and noncompetitive NMDA receptor antagonist: The role in emotional control Plaznik, A.
1994
4 3 p. 335-
1 p.
artikel
252 The molecular cloning of the dopamine receptors and the discovery of the dopamine D4 receptor Civelli, Olivier
1994
4 3 p. 189-190
2 p.
artikel
253 The neurobiological consequences of early traumatic experiences: focus on corticotropin-releasing factor Nemeroff, C.B.
1994
4 3 p. 255-256
2 p.
artikel
254 The NOSGER (nurses' observation scale for geriatric patients): new dara regarding its validity and sensitivity to change Spiegel, R.
1994
4 3 p. 413-
1 p.
artikel
255 The panic and agoraphobia scale: results of validation processes Bandelow, B.
1994
4 3 p. 347-348
2 p.
artikel
256 The pharmacology of excitatory amino acid antagonists in an animal model of stroke Gill, R.
1994
4 3 p. 279-281
3 p.
artikel
257 The psychobiology of obsessive-compulsive disorder Weizman, Abraham
1994
4 3 p. 247-
1 p.
artikel
258 The role of hippocampal 5-hydroxytryptamine-1A (5-HT1A) receptors in the anticonflict activity of β-adrenoceptor antagonists Tatarczyńska, E.
1994
4 3 p. 436-437
2 p.
artikel
259 The role of nerve growth factor family receptors in the development of the mammalian nervous system Fagan, A.M.
1994
4 3 p. 226-
1 p.
artikel
260 The role of serotonin in the pathophysiology of panic disorder Khan, R.S.
1994
4 3 p. 200-202
3 p.
artikel
261 The role of the different types of opioid receptors in the effects of N-cyclopropylmethyl homologues of morphine Friedmann, T.
1994
4 3 p. 441-
1 p.
artikel
262 The safety of newer and older antipsychotics King, D.J.
1994
4 3 p. 220-221
2 p.
artikel
263 The spectrum of effects of cholinergic treatment of Alzheimer's disease patients Siegfried, K.R.
1994
4 3 p. 241-243
3 p.
artikel
264 Tiapride with senile psychoses. The effect on negative symptoms of schizophrenia Bukatina, E.E.
1994
4 3 p. 389-
1 p.
artikel
265 Time of drinking, sleep restriction, and the sedative effects of ethanol Rosenthal, L.
1994
4 3 p. 437-438
2 p.
artikel
266 Towards an understanding of acute oral dyskinesia in sensitized animals. An evaluation of dopaminergic and cholinergic mechanisms Lublin, H.
1994
4 3 p. 382-
1 p.
artikel
267 Toxicity of excitatory amino acids and neuroprotection by non-competitive NMDA antagonists Privat, A.
1994
4 3 p. 262-263
2 p.
artikel
268 Transcranial magnetic stimulation in depression and schizophrenia Grisaru, N.
1994
4 3 p. 287-288
2 p.
artikel
269 Treatment of a bipolar psychotic refractory depression with clozapine: a case report Abbar, M.
1994
4 3 p. 305-
1 p.
artikel
270 Treatment of drug-induced psychosis in Parkinson's disease with clozapine: a case report Courtet, P.
1994
4 3 p. 377-
1 p.
artikel
271 Treatment of school phobia in children and adolescents with fluoxetine Da̧bkowska, M.
1994
4 3 p. 353-
1 p.
artikel
272 Treatment of the cholinergic impairment in Alzheimer's disease Wilcock, G.K.
1994
4 3 p. 239-240
2 p.
artikel
273 Ultrabrief pulse compared to sine wave ECT: a double-blind prospective randomized controlled study Seifertová, B.
1994
4 3 p. 329-330
2 p.
artikel
274 Use of low-dose selective serotonin reuptake inhibitors and cognitive behavioral therapy in agoraphobia with panic attacks: an open study Dutoit, D.
1994
4 3 p. 350-
1 p.
artikel
275 Use of α-tocopherol for correction of movement disorders in long-term neuroleptic treatment Dikaya, V.I.
1994
4 3 p. 366-
1 p.
artikel
276 Utilisation study: fluvoxamine in the treatment of depression in general practice Jaquenoud, E.
1994
4 3 p. 291-292
2 p.
artikel
277 Validity of the anticipatory cognitive questionnaire in depression: A multicenter study (preliminary results) López-Ibor Jr., J.J.
1994
4 3 p. 293-
1 p.
artikel
278 Vitamin E treatment of persistent tardive dyskinesia: a double-blind, placebo-controlled, cross-over study Cavallaro, R.
1994
4 3 p. 375-
1 p.
artikel
279 What response is clinically important in negative schizophrenia? Barnes, Thomas R.E.
1994
4 3 p. 282-
1 p.
artikel
280 Zuclopenthixol co-injection in acute exacerbation of chronic psychosis in Finland and Estonia Vartiainen, H.
1994
4 3 p. 383-
1 p.
artikel
                             280 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland